Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Anxiety Disorders News
ADAALurasidone Appears Safe in Kids With Bipolar DepressionLurasidone, approved for bipolar depression in children and adolescents on the basis of 6-week findings from a phase 3 trial, is also safe and effective for up to 28 weeks, new open-label data show.
Medscape Medical News, April 18, 2018
ADAA'Fear of Fear' May Influence OCD, PTSD OutcomesAnxiety sensitivity, commonly referred to as the 'fear of fear,' may affect treatment outcomes in patients with OCD; treatment preference may influence anxiety sensitivity outcomes in patients with PTSD.
